# Effects of Homocysteine in Myocardial Infarction Patients in a Tertiary Care Hospital of Pakistan

> **NCT05011032** · NA · WITHDRAWN · sponsor: **Aqua Medical Services (Pvt) Ltd**

## Conditions studied

- Homocystine; Metabolic Disorder

## Interventions

- **DIAGNOSTIC_TEST:** Homocysteine

## Key facts

- **NCT ID:** NCT05011032
- **Lead sponsor:** Aqua Medical Services (Pvt) Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-08-12
- **Primary completion:** 2021-09-09
- **Final completion:** 2021-09-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Ethical approval was not done. Hence the funding was withhold.
- **Last updated:** 2021-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05011032

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05011032, "Effects of Homocysteine in Myocardial Infarction Patients in a Tertiary Care Hospital of Pakistan". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT05011032. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*